Genentech, Inc.
Verified Pharmaceutical Manufacturer & Oncology Drug Supplier
Genentech, Inc.
Verified PartnerRegistered pharmaceutical manufacturer and healthcare technology supplier listed on the ONC-ORG national directory.
Company Profile & Registration
Legal Organization NameGenentech, Inc.
Manufacturer Identification CodeRegistered
Authorized RepresentativeCorporate Representative
Compliance & StatusActive / Listed
Oncology Drugs & Clinical Formulations
Featured Drug Formulation
View Complete Drug Profile Herceptin
Generic: trastuzumab
Class: HER2-Directed Monoclonal Antibody
Indications: Adjuvant treatment of HER2-overexpressing node-positive or node-negative breast cancer, metastatic HER2-overexpressing breast cancer, and HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.
Direct Communication & Assistance
Send an Inquiry to Genentech, Inc.
Our oncology navigation desk will route your inquiry regarding medicine access, clinical partnerships, or product availability to the appropriate representative.
